Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07501871

Investigation of Digital Media Use in Patients Receiving Chemotherapy

This study aims to examine digital media use and eHealth literacy among patients receiving chemotherapy. Digital media has become an important tool for accessing health information, communicating with healthcare providers, and supporting self-management.

This observational study will be conducted with adult patients receiving chemotherapy in an outpatient setting. Data will be collected using a sociodemographic information form and the eHealth Literacy Scale (eHEALS). The findings are expected to contribute to a better understanding of digital media use and digital health literacy levels in chemotherapy patients.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Cancer Chemotherapy Neoplasms

Age range

18 year–67 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Acıbadem University Atakent Hospital

Istanbul, Küçükçekmece, Turkey (Türkiye)

About this study

Cancer is a major global health problem, and chemotherapy is one of the most commonly used treatment methods. With the increasing use of digital media, patients frequently access health-related information, communicate with healthcare providers, and engage in self-management. Digital health literacy plays a key role in this process.

This study aims to describe digital media use and eHealth literacy levels among patients receiving chemotherapy. It will also explore the relationship between digital media use and selected patient characteristics.

The study will be conducted as a descriptive, cross-sectional observational study in an outpatient chemotherapy setting. Data will be collected using a sociodemographic information form and the eHealth Literacy Scale (eHEALS).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients aged between 18 and 67 years
  • Receiving chemotherapy treatment
  • Able to communicate and understand the study procedures
  • Voluntarily agree to participate in the study

Exclusion criteria

  • Patients with cognitive impairment or communication difficulties
  • Patients who refuse to participate
  • Patients with incomplete questionnaire responses

Treatment and study plan

No intervention (observational study)

Other

This is an observational study with no assigned intervention. Data will be collected through surveys assessing digital media use and eHealth literacy.

Primary outcomes

  1. Digital Media Use Level

    Time frame: At baseline (during chemotherapy treatment)

    Digital media use will be evaluated based on frequency, duration, and purpose of use through a structured questionnaire.

Secondary outcomes

  1. eHealth Literacy Level

    Time frame: At baseline

    eHealth literacy will be assessed using the eHealth Literac Scale (eHEALS)

Other outcomes

  1. Relationship Between Digital Media Use and eHealth Literacy

    Time frame: At baseline

    The association between digital media use and eHealth literacy will be analyzed using statistical methods.

Study contacts

Contact information is provided by the study sponsor or research team.

Emine Ilayda Yildiz, RN

CONTACT

[email protected]

+905436411944

Sponsors and collaborators

Lead sponsor

Fenerbahce University

Other

Registry information

Official study title

Assessment of Digital Meda Use and eHealth Literacy in Patients Receiving Chemotherapy

Acronym: DMU-CH

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Mar 30, 2026
Registry last updated
Apr 21, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.